How close is China’s EUV project to eliminating ASML’s monopoly?

Chinese state-led investment and a reported team including former ASML engineers have produced a working EUV lithography prototype in Shenzhen, part of a multi-year push to build a domestic EUV ecosystem and bypass Dutch/US export controls. If scaled into mass-production by 2028–2030, the development would materially weaken Western export leverage, force replication of a complex global supply chain (notably optics suppliers like Carl Zeiss), and reshape competitive dynamics across semiconductor equipment and foundry suppliers, though significant supply-chain and energy hurdles remain.

Analysis

Market structure: near-term winners are non-Chinese advanced foundries (TSM, Samsung) and western suppliers of ASML-dependent capacity because China’s blockade concentrates demand; expect foundry pricing power to support TSM’s 10–25% margin premium versus peers over the next 12 months. ASML is a bifurcated story — durable IP moat but increased downside risk if China achieves workable EUV by 2028–2030 (scenario could shave 5–15% off ASML’s revenue long-term). Critical losers: firms relying on protected market access to China and semicap suppliers exposed to decoupling.

Risk assessment: tail risks include a) China fielding commercially viable in-house EUV pre-2028 (low probability, high impact), b) tighter Western export controls or talent mobility bans, and c) supply-chain chokepoints (Carl Zeiss optics, exotic gases) being cut off. Time horizons: expect immediate market noise (days, ±5–10% on headlines), re-rating over months (6–12) as supply responses materialize, and structural shifts by 2028–2032. Hidden dependencies: vacuum/laser subsystems and IP litigation are second-order failure points that can stall Chinese scaling even if a prototype exists.

Trade implications: tactical positions should be asymmetric — protect exposure to ASML while capturing foundry upside. Priority: overweight TSM (TSM) for 6–18 months to capture capacity scarcity; use options to hedge concentrated semicap risk. Commodities (neon/helium) and listed suppliers of precision optics merit a 6–24 month watchlist as liquidity and pricing will spike if fragmentation accelerates.

Contrarian angles: consensus underestimates the difficulty of replicating the supplier ecosystem — ASML-like mass production requires more than leaked designs; expect multi-year lag and quality delta. Market may overprice a rapid Chinese catch-up; a measured response is to buy selective downside protection on ASML while adding to secular winners (TSM) on any headline-driven dip. Unintended consequence: Western firms will accelerate localization subsidies, creating new winners among US/EU toolmakers and foundries.

Key Decisions for Investors

• Establish a 2–3% long position in TSM (TSM) over 6–18 months with a 12-month target +20% and a stop-loss at -10%; rationale: concentrated advanced-node capacity and pricing power if China remains behind by 2–4 nodes.
• Deploy a protective hedge on ASML: buy a 6–9 month put spread sized 0.5–0.75% of portfolio notional (pay 12% OTM put / sell 20% OTM put) to cap 8–15% downside from geopolitical/technological surprise; if ASML drops >15% add a second tranche to bring hedge to 1.5% notional.
• Initiate a 1–2% tactical long in INTC for 12–24 months (target +15%) to play Western onshoring and EU/US subsidy capture; exit if Intel misses a key roadmap milestone (process node tapeout delays >6 months).
• If within 30–90 days independent reporting confirms full-system prototypes entering wafer runs or evidence of replacement optical imports (e.g., shipments substituting Carl Zeiss components), reduce ASML/European semicap exposure by 50% and open a 1–2% short in selected European semicap names; conversely, if no such confirmations in 6 months, add to ASML on >10% dip.